Global leaders in obesity research plus hundreds of medical, scientific, & academic associations and institutions have taken this pledge to end the stigma.
Obesity stigma is pervasive & resilient. A landmark statement demands we eliminate the gap between the social narrative and scientific evidence.
A new orally disintegrating tablet formulation of CGRP inhibitor rimegepant may restore normal function within 1 hour in adults with migraine, according to the manufacturer.
Antihypertension drugs deliver similar reduction in CV events, a new study finds. Message: Focus on reaching target BP, not on drug class.
More than 50% of patients with obesity say weight loss is a priority for them. What percentage of their physicians feel the same? #ObesityCareWeek
Irregular sleep patterns in women may impact quality of diet and calories consumed, increasing risk for cardiometabolic disease, concludes a new study.
Liraglutide added to intensive behavior therapy in primary care practice significantly improved weight loss vs behavior therapy alone, a new study found.
Elements of proper blood pressure measurement technique may seem picayune, but skipping them may cost you - here's how much.
Based on results from REWIND, dulaglutide is the first GLP-1 receptor agonist to be approved for both primary and secondary CV prevention in type 2 diabetes.
Influenza activity remains high, according to the CDC's weekly surveillance report, but mortality is below the epidemic threshold.